BTC Health Limited
Research BTC Health Limited (BTC.AX) on Bullrun: market cap AUD 17.16M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBTC.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryBiotechnology
- CurrencyAUD
- Market capAUD 17.16M
- Financial periodFY2026
- Net incomeAUD 34.73K
- Free cash flow-AUD 353.88K
Valuation Snapshot
latest market cap is AUD 17.16M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | n/a | AUD 34.73K | -AUD 353.88K | n/a | n/a | AUD 1.47M | n/a | AUD 11.21M |
| FY2025 | n/a | AUD 3.98M | -AUD 499.98K | n/a | 0.01 | AUD 620.11K | n/a | AUD 9.16M |
| FY2024 | n/a | AUD 1.06M | -AUD 404.76K | n/a | 0 | AUD 2.02M | n/a | AUD 4.94M |
| FY2023 | n/a | -AUD 10.17M | -AUD 433.61K | n/a | -0.04 | AUD 1.74M | n/a | AUD 2.78M |
| FY2022 | AUD 94.37K | n/a | n/a | 100.0% | 0 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-10 | AUD 17.16M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About BTC Health Limited
BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd specializing in seed/startup, early venture, mid venture, late venture, emerging growth and growth capital investments. It makes investments in the healthcare, acute pain management, neuro-spinal, cardiovascular, pharmaceutical, medical technologies, biotechnology sector with a focus on post-genomics, stem cell biology, convergence, silicon biology, and nanomedicine.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is BTC Health Limited's market cap?
BTC Health Limited's market capitalization is AUD 17.16M.
What does BTC Health Limited do?
BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd specializing in seed/startup, early venture, mid venture, late venture, emerging growth and growth capital investments. It makes investments in the healthcare, acute pain management, neuro-spinal, cardiovascular, pharmaceutical, medical technologies, biotechnology sector with a focus on post-genomics, stem cell biology, convergence, silicon biology, and nanomedicine. Within post-genomics, it invests in functional genomics, transcriptomics, proteomics, structural genomics, glycomics, and pharmacogenomics.